Holding(s) in Company

Finsbury Emerging Biotechnology Tst
01 June 2006

                                   SCHEDULE 10

                    NOTIFICATION OF MAJOR INTERESTS IN SHARES


1. Name of company

FINSBURY EMERGING BIOTECHNOLOGY TRUST PLC

2. Name of shareholder having a major interest

THE CAYENNE TRUST plc

3. Please state whether notification indicates that it is in respect of holding
of the shareholder named in 2 above or in respect of a non-beneficial interest
or in the case of an individual holder if it is a holding of that person's
spouse or children under the age of 18

AS IN 2 ABOVE

4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them

AS IN 2 ABOVE

5. Number of shares / amount of stock acquired

935,366

6. Percentage of issued class

1.42%

7. Number of shares / amount of stock disposed

NIL

8. Percentage of issued class

N/A

9. Class of security

ORDINARY SHARES OF 25P EACH

10. Date of transaction

25 MAY 2006

11. Date company informed

31 MAY 2006

12. Total holding following this notification

935,366

13. Total percentage holding of issued class following this notification

1.42%

14. Any additional information

* Based on the issued share capital of 65,912,263 Ordinary shares, following the
announcement, on 24 May 2006, of the issue price and basis of allocation of new
Ordinary shares concerning a  Placing and Offer for Subscription.

15. Name of contact and telephone number for queries

MARK POPE - 020 7426 6294

16. Name and signature of authorised company official responsible for making
this notification

TRACEY LAGO

FOR AND ON BEHALF OF CLOSE FINSBURY ASSET MANAGEMENT LIMITED, SECRETARY

Date of notification

1 JUNE 2006

The FSA does not give any express or implied warranty as to the accuracy of this
document or material and does not accept any liability for error or omission.
The FSA is not liable for any damages (including, without limitation, damages
for loss of business or loss of profits) arising in contract, tort or otherwise
from the use of or inability to use this document, or any material contained in
it, or from any action or decision taken as a result of using this document or
any such material.


                      This information is provided by RNS
            The company news service from the London Stock Exchange